When examining patients with lipoprotein glomerulopathy, Oikawa et al. (1991) found that the Arg163Pro point mutation could cause a lower affinity for the LDL receptor (LDLR)28. This evidence concerns the gene LDLR and lipoprotein glomerulopathy.